Sign Up to like & get
recommendations!
2
Published in 2023 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2023.1449
Abstract: Importance Symptomatic intracranial hemorrhage (sICH) is a serious complication of stroke thrombolytic therapy. Many stroke centers have adopted 0.25-mg/kg tenecteplase instead of alteplase for stroke thrombolysis based on evidence from randomized comparisons to alteplase as…
read more here.
Keywords:
tenecteplase;
acute ischemic;
tenecteplase alteplase;
stroke ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s170803
Abstract: Background Recent studies showed inconsistent results of tenecteplase vs alteplase for acute ischemic stroke (AIS) with safety and efficacy. Methods A meta-analysis was performed to explore the value of tenecteplase and alteplase in AIS treatment.…
read more here.
Keywords:
tenecteplase alteplase;
neurological improvement;
tenecteplase showed;
tenecteplase ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2023.1102463
Abstract: Background and objectives Several randomized controlled trials (RCTs) have compared tenecteplase to alteplase for treatment of acute ischemic stroke (AIS). Yet, there is no meta-analysis that includes the latest published RCTs of 2022. We sought…
read more here.
Keywords:
meta analysis;
tenecteplase alteplase;
alteplase treatment;
value ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Medicina"
DOI: 10.3390/medicina58091169
Abstract: Background and Objectives: The study aimed to investigate the efficacy of intravenous thrombolysis with Tenecteplase before thrombectomy for acute ischemic stroke (AIS) patients compared with previous results using Alteplase. Previous trials for Tenecteplase have indicated…
read more here.
Keywords:
occlusion;
tenecteplase;
acute ischemic;
tenecteplase alteplase ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Stroke"
DOI: 10.5853/jos.2018.01998
Abstract: The Extending the time for Thrombolysis in Emergency Neurological Deficits–Intra-Arterial using Tenecteplase (EXTEND-IA TNK) trial recently showed 2-fold higher early recanalization (ER) rate before mechanical thrombectomy (MT) following intravenous thrombolysis (IVT) with tenecteplase 0.25 mg/kg,…
read more here.
Keywords:
tenecteplase alteplase;
recanalization thrombectomy;
drip ship;
alteplase ... See more keywords